General American Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

General American Investors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-261,780	Closed	-$21.9M	–	71
2024 Q4	$21.9M	Hold	261,780	–	–	1.52%	20
2024 Q3	$19.2M	Hold	261,780	–	–	1.32%	23
2024 Q2	$17.9M	Buy	261,780 +1,341	+0.5%	+$93K	1.25%	21
2024 Q1	$18M	Hold	260,439	–	–	1.29%	20
2023 Q4	$18.7M	Hold	260,439	–	–	1.48%	19
2023 Q3	$13.6M	Hold	260,439	–	–	1.22%	25
2023 Q2	$16.5M	Hold	260,439	–	–	1.44%	21
2023 Q1	$14.1M	Sell	260,439 -23,000	-8%	-$1.11M	1.33%	24
2022 Q4	$15M	Hold	283,439	–	–	1.47%	23
2022 Q3	$13.2M	Hold	283,439	–	–	1.37%	28
2022 Q2	$16.2M	Hold	283,439	–	–	1.63%	20
2022 Q1	$17.3M	Hold	283,439	–	–	1.42%	25
2021 Q4	$14.8M	Sell	283,439 -67,365	-19%	-$2.83M	1.16%	30
2021 Q3	$13.1M	Hold	350,804	–	–	1.11%	35
2021 Q2	$14.3M	Buy	350,804 +3,307	+1%	+$122K	1.2%	30
2021 Q1	$11.8M	Hold	347,497	–	–	1.1%	34
2020 Q4	$11.1M	Hold	347,497	–	–	1.09%	33
2020 Q3	$8.92M	Buy	347,497 +80,970	+30%	+$1.85M	1.03%	32
2020 Q2	$6.84M	Hold	266,527	–	–	0.87%	34
2020 Q1	$4.1M	Sell	266,527 -65,000	-20%	-$1.41M	0.55%	40
2019 Q4	$11.4M	Sell	331,527 -10,000	-3%	-$120K	1.04%	36
2019 Q3	$2.55M	Buy	341,527 +41,585	+14%	+$399K	0.25%	62
2019 Q2	$3.89M	Hold	299,942	–	–	0.37%	58
2019 Q1	$3.65M	Hold	299,942	–	–	0.36%	59
2018 Q4	$3.42M	Buy	+299,942	New	+$4.84M	0.36%	59

Other funds holding ITCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

General American Investors's ITCI Position: Q1 2025 in Review

General American Investors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 261,780 shares — an estimated $21.9M sold.

General American Investors first reported a position in ITCI in Q4 2018 and held it in 25 quarters. The position peaked at $21.9M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

General American Investors reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
General American Investors sold 261,780 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $21.9M.
General American Investors first reported a position in Intra-Cellular Therapies Inc. in Q4 2018 and held it in 25 quarters.
General American Investors's Intra-Cellular Therapies Inc. position peaked at $21.9M in Q4 2024.
395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on General American Investors's 13F filing for Q1 2025, filed 2 May 2025.